VC
Publicaties op Oncologisch.com
High-dose busulfan-melphalan vs melphalan and reinforced VRD for newly diagnosed multiple myeloma: a phase 3 GEM trial.
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfil...
Lenalidomide-dexamethason onderhoud met of zonder ixazomib op basis van restziekte bij myeloom
IMWG responscriteria validatie bij myeloom: PETHEMA/GEM2012MENOS65